These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

370 related items for PubMed ID: 1692065

  • 1. Cyclosporin A rapidly inhibits mediator release from human basophils presumably by interacting with cyclophilin.
    Cirillo R, Triggiani M, Siri L, Ciccarelli A, Pettit GR, Condorelli M, Marone G.
    J Immunol; 1990 May 15; 144(10):3891-7. PubMed ID: 1692065
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Nimesulide, a sulfonanilide nonsteroidal anti-inflammatory drug, inhibits mediator release from human basophils and mast cells.
    Casolaro V, Meliota S, Marino O, Patella V, de Paulis A, Guidi G, Marone G.
    J Pharmacol Exp Ther; 1993 Dec 15; 267(3):1375-85. PubMed ID: 7505332
    [Abstract] [Full Text] [Related]

  • 4. Cyclosporin H is a potent and selective competitive antagonist of human basophil activation by N-formyl-methionyl-leucyl-phenylalanine.
    de Paulis A, Ciccarelli A, de Crescenzo G, Cirillo R, Patella V, Marone G.
    J Allergy Clin Immunol; 1996 Jul 15; 98(1):152-64. PubMed ID: 8765829
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. The human recombinant c-kit receptor ligand, rhSCF, induces mediator release from human cutaneous mast cells and enhances IgE-dependent mediator release from both skin mast cells and peripheral blood basophils.
    Columbo M, Horowitz EM, Botana LM, MacGlashan DW, Bochner BS, Gillis S, Zsebo KM, Galli SJ, Lichtenstein LM.
    J Immunol; 1992 Jul 15; 149(2):599-608. PubMed ID: 1378071
    [Abstract] [Full Text] [Related]

  • 7. Signal transduction events in human basophils. A comparative study of the role of protein kinase C in basophils activated by anti-IgE antibody and formyl-methionyl-leucyl-phenylalanine.
    Warner JA, MacGlashan DW.
    J Immunol; 1990 Sep 15; 145(6):1897-905. PubMed ID: 1697313
    [Abstract] [Full Text] [Related]

  • 8. The ascomycin macrolactam pimecrolimus (Elidel, SDZ ASM 981) is a potent inhibitor of mediator release from human dermal mast cells and peripheral blood basophils.
    Zuberbier T, Chong SU, Grunow K, Guhl S, Welker P, Grassberger M, Henz BM.
    J Allergy Clin Immunol; 2001 Aug 15; 108(2):275-80. PubMed ID: 11496246
    [Abstract] [Full Text] [Related]

  • 9. In vivo characterization of the anti-inflammatory effect of cyclosporin A on human basophils.
    Casolaro V, Spadaro G, Patella V, Marone G.
    J Immunol; 1993 Nov 15; 151(10):5563-73. PubMed ID: 7693814
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Characteristics of human basophil sulfidopeptide leukotriene release: releasability defined as the ability of the basophil to respond to dimeric cross-links.
    MacGlashan DW, Peters SP, Warner J, Lichtenstein LM.
    J Immunol; 1986 Mar 15; 136(6):2231-9. PubMed ID: 2419427
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. The mechanism of mediator release from human basophils induced by platelet-activating factor.
    Columbo M, Casolaro V, Warner JA, MacGlashan DW, Kagey-Sobotka A, Lichtenstein LM.
    J Immunol; 1990 Dec 01; 145(11):3855-61. PubMed ID: 1700998
    [Abstract] [Full Text] [Related]

  • 14. Anti-inflammatory effect of cyclosporin A on human skin mast cells.
    Stellato C, de Paulis A, Ciccarelli A, Cirillo R, Patella V, Casolaro V, Marone G.
    J Invest Dermatol; 1992 May 01; 98(5):800-4. PubMed ID: 1373749
    [Abstract] [Full Text] [Related]

  • 15. The effect of pertussis toxin on mediator release from human basophils.
    Warner JA, Yancey KB, MacGlashan DW.
    J Immunol; 1987 Jul 01; 139(1):161-5. PubMed ID: 2438348
    [Abstract] [Full Text] [Related]

  • 16. Cyclosporin A inhibits degranulation of rat basophilic leukemia cells and human basophils. Inhibition of mediator release without affecting PI hydrolysis or Ca2+ fluxes.
    Hultsch T, Rodriguez JL, Kaliner MA, Hohman RJ.
    J Immunol; 1990 Apr 01; 144(7):2659-64. PubMed ID: 1690774
    [Abstract] [Full Text] [Related]

  • 17. Heterogeneity of signal transduction mechanisms in human basophils and human skin mast cells. II. Effects of 7-O-methyl-UCN-01, NPC 15437 and bryostatin 1 and 2, four protein kinase C-modulatory agents, on mediator release.
    Noll T, Dieckmann D, Gibbs BF, Nitschke M, Albrecht C, Vollrath I, Tamaoki T, Wolff HH, Amon U.
    Biol Signals; 1997 Apr 01; 6(1):1-10. PubMed ID: 9098518
    [Abstract] [Full Text] [Related]

  • 18. Protein L. A bacterial Ig-binding protein that activates human basophils and mast cells.
    Patella V, Casolaro V, Björck L, Marone G.
    J Immunol; 1990 Nov 01; 145(9):3054-61. PubMed ID: 1698870
    [Abstract] [Full Text] [Related]

  • 19. The antineoplastic bryostatins affect human basophils and mast cells differently.
    Patella V, Casolaro V, Ciccarelli A, Pettit GR, Columbo M, Marone G.
    Blood; 1995 Mar 01; 85(5):1272-81. PubMed ID: 7532037
    [Abstract] [Full Text] [Related]

  • 20. Differential activation of human basophils by anti-IgE and formyl-methionyl-leucyl-phenylalanine. Indications for protein kinase C-dependent and -independent activation pathways.
    Knol EF, Koenderman L, Mul FP, Verhoeven AJ, Roos D.
    Eur J Immunol; 1991 Apr 01; 21(4):881-5. PubMed ID: 1708341
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 19.